These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7636928)

  • 1. Lymphoma as a cause of false positive serology for visceral leishmaniasis (kala-azar) using the indirect haemagglutination (IHA) method.
    Malik GM; Abdalla RE; al-Knawy B; Abdalla SE
    J Trop Med Hyg; 1995 Aug; 98(4):285-6. PubMed ID: 7636928
    [No Abstract]   [Full Text] [Related]  

  • 2. False positive serology for visceral leishmanias (kala-azar) using the indirect haemagglutination (IHA) method.
    Malik GM; Reshi SH; Abdalla SE
    J Trop Med Hyg; 1992 Feb; 95(1):67-70. PubMed ID: 1740822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of counterimmunoelectrophoresis and indirect haemagglutination tests for the immunoepidemiological investigation of kala-azar.
    Khan NI; Desowitz RS
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):377-80. PubMed ID: 4095600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widal reaction in Kala-azar.
    Singh UK; Sinha RK; Sharma VK
    Indian Pediatr; 1995 Jun; 32(6):680-3. PubMed ID: 8613339
    [No Abstract]   [Full Text] [Related]  

  • 6. On the specificity of the indirect haemagglutination in diagnosis of visceral leishmaniasis.
    Morsy TA; Ahmed MM; Younis TA; Arafa MM
    J Egypt Soc Parasitol; 1990 Jun; 20(1):231-4. PubMed ID: 2332651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
    Dhar S; Malakar S
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
    Ramesh V
    Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative studies on IFAT, ELISA & DAT for serodiagnosis of visceral leishmaniasis in Bangladesh.
    Alam MJ; Rahman KM; Asna SM; Muazzam N; Ahmed I; Chowdhury MZ
    Bangladesh Med Res Counc Bull; 1996 Apr; 22(1):27-32. PubMed ID: 9037842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An indirect immunoperoxidase assay for rapid serodiagnosis of visceral leishmaniasis.
    Jain A; Agrawal M; Tiwari V
    Indian J Exp Biol; 1994 Nov; 32(11):822-5. PubMed ID: 7896312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodiagnosis of kala-azar.
    Srivastava L
    J Commun Dis; 1985; 17(1 Suppl):83-8. PubMed ID: 3913701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Syndrome of inappropriate macrophage activation associated with infantile visceral leishmaniasis].
    Thabet F; Tabarki B; Fehem R; Yacoub M; Selmi H; Essoussi AS
    Tunis Med; 1999 Dec; 77(12):648-50. PubMed ID: 10730157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver biopsy in the diagnosis of visceral leishmaniasis.
    Artan R; Yilmaz A; Akçam M; Aksoy NH
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):299-302. PubMed ID: 16460490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis (kala-azar) in Gujarat.
    Vaishnav VP; Shah CP; Shah BR; Sanghavi NG; Dave JM
    J Indian Med Assoc; 1970 Jan; 54(2):66-70. PubMed ID: 5418149
    [No Abstract]   [Full Text] [Related]  

  • 18. An unusual presentation of post-kala-azar dermal leishmaniasis.
    Ramesh V; Kumar J; Salotra P
    Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of counter immunoelectrophoresis as a diagnostic tool in kala-azar.
    Aikat BK; Sehgal S; Mahajan RC; Pathania AG; Bhattacharya PK; Sahaya S; Choudhury AB; Pasricha N; Prasad LS
    Indian J Med Res; 1979 Oct; 70():592-7. PubMed ID: 541005
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual features in kala-azar: a case report.
    Chowdhury AH; Islam N
    Bangladesh Med Res Counc Bull; 1986 Dec; 12(2):99-104. PubMed ID: 3566688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.